top of page

Tirzepatide is a dual GLP-1 and GIP receptor co-agonist that simultaneously activates two distinct incretin hormone pathways. It is one of the most mechanistically advanced metabolic research peptides available, studied for its synergistic effects on appetite suppression, insulin sensitivity, and fat mass reduction through combined GLP-1R and GIPR activation.

Tirzepatide

From $100.00Sale Price
Quantity
bottom of page